<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: TheraGenetics Bought by Avacta</title>
	<atom:link href="http://www.xconomy.com/boston/2009/01/29/theragenetics-bought-by-avacta/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/01/29/theragenetics-bought-by-avacta/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:08:02 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Who&#8217;s Getting Paid: The Week in Deals &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries</title>
		<link>http://www.xconomy.com/boston/2009/01/29/theragenetics-bought-by-avacta/comment-page-1/#comment-45298</link>
		<dc:creator>Who&#8217;s Getting Paid: The Week in Deals &#124; IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries</dc:creator>
		<pubDate>Mon, 02 Feb 2009 18:50:20 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=10839#comment-45298</guid>
		<description>[...] Theragenetics is another not-so-well know company that develops diagnostic tests for various CNS diseases. The company announced back in January that contract service provider Avacta would be acquiring them for $2.9M. Peanuts. [Xconomy] [...]</description>
		<content:encoded><![CDATA[<p>[...] Theragenetics is another not-so-well know company that develops diagnostic tests for various CNS diseases. The company announced back in January that contract service provider Avacta would be acquiring them for $2.9M. Peanuts. [Xconomy] [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

